| Tatva Chintan Pharma Chem Ltd | Industry : (Chemicals) | |
|---|---|---|
|
BSE Code : 543321 |
NSE Symbol : TATVA |
P/E(TTM) : 86.11 |
|
ISIN Demat : INE0GK401011 |
Div & Yield% : 0.09 |
EPS(TTM) : 13.32 |
|
Book Value(₹) : 313.31 |
Market Cap(₹Cr) : 2,683.07 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 138.59 | 115.86 | 109.18 | 107.65 | 84.00 | 80.96 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 138.59 | 115.86 | 109.18 | 107.65 | 84.00 | 80.96 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.73 | 0.79 | 1.37 | 1.30 | 0.04 | 0.81 |
| Total Income | 140.32 | 116.66 | 110.55 | 108.94 | 84.04 | 81.77 |
| Total Expenditure | 111.97 | 94.75 | 94.11 | 99.75 | 78.35 | 76.36 |
| PBIDT | 28.35 | 21.90 | 16.44 | 9.20 | 5.69 | 5.41 |
| Interest | 0.49 | 0.51 | 0.41 | 0.39 | 0.42 | 0.17 |
| PBDT | 27.86 | 21.40 | 16.02 | 8.81 | 5.27 | 5.23 |
| Depreciation | 9.07 | 9.05 | 8.97 | 7.26 | 6.92 | 6.81 |
| Tax | 4.14 | 2.14 | 1.21 | -0.01 | -0.06 | -0.29 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -1.33 | 1.26 | 0.71 | 0.47 | -0.43 | -0.18 |
| Reported Profit After Tax | 15.98 | 8.94 | 5.13 | 1.10 | -1.17 | -1.11 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 15.98 | 8.94 | 5.13 | 1.10 | -1.17 | -1.11 |
| EPS (Unit Curr.) | 6.84 | 3.82 | 2.19 | 0.47 | -0.50 | -0.47 |
| EPS (Adj) (Unit Curr.) | 6.84 | 3.82 | 2.19 | 0.47 | -0.50 | -0.47 |
| Calculated EPS (Unit Curr.) | 6.83 | 3.82 | 2.19 | 0.47 | -0.50 | -0.47 |
| Calculated EPS (Adj) (Unit Curr.) | 6.83 | 3.82 | 2.19 | 0.47 | -0.50 | -0.47 |
| Calculated EPS (Ann.) (Unit Curr.) | 27.33 | 15.29 | 8.78 | 1.87 | -1.99 | -1.90 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 27.33 | 15.29 | 8.78 | 1.87 | -1.99 | -1.90 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 23.39 | 23.39 | 23.39 | 23.39 | 23.39 | 23.39 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 20.46 | 18.90 | 15.06 | 8.55 | 6.77 | 6.68 |
| PBDTM(%) | 20.10 | 18.47 | 14.67 | 8.18 | 6.27 | 6.46 |
| PATM(%) | 11.53 | 7.72 | 4.70 | 1.02 | -1.39 | -1.37 |
